SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-24-000774
Filing Date
2024-02-29
Accepted
2024-02-29 16:37:40
Documents
66
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2431039.htm   iXBRL 20-F 2486182
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 452665
3 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 9913
4 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 4575
5 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 5201
6 EXHIBIT 97.1 exhibit_97-1.htm EX-97. 64343
12 GRAPHIC image0.jpg GRAPHIC 100139
13 GRAPHIC image00001.jpg GRAPHIC 21304
  Complete submission text file 0001178913-24-000774.txt   9644132

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE prfx-20231231.xsd EX-101.SCH 72562
8 XBRL CALCULATION FILE prfx-20231231_cal.xml EX-101.CAL 43035
9 XBRL DEFINITION FILE prfx-20231231_def.xml EX-101.DEF 193806
10 XBRL LABEL FILE prfx-20231231_lab.xml EX-101.LAB 743139
11 XBRL PRESENTATION FILE prfx-20231231_pre.xml EX-101.PRE 320368
68 EXTRACTED XBRL INSTANCE DOCUMENT zk2431039_htm.xml XML 1363279
Mailing Address 65 YIGAL ALON ST. TEL AVIV L3 6744316
Business Address 65 YIGAL ALON ST. TEL AVIV L3 6744316 972-3-7177051
PAINREFORM LTD. (Filer) CIK: 0001801834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39481 | Film No.: 24704468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)